Clinical Trial Update: Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fosfomycin to meropenem or ceftriaxone for bacteremic infections due to multidrug-resistant ESBL-producing Escherichia coli; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection Due to Esbl Escherichia Coli

Drugs mentioned

• Fosfomycin (Fosfomycin)
• Meropenem (Meropenem)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Infection Due to ESBL Escherichia Coli | Phase 3 | Status: COMPLETED